Cargando…
Effect of Chitosan Properties on Immunoreactivity
Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882565/ https://www.ncbi.nlm.nih.gov/pubmed/27187416 http://dx.doi.org/10.3390/md14050091 |
_version_ | 1782434135824924672 |
---|---|
author | Ravindranathan, Sruthi Koppolu, Bhanu prasanth Smith, Sean G. Zaharoff, David A. |
author_facet | Ravindranathan, Sruthi Koppolu, Bhanu prasanth Smith, Sean G. Zaharoff, David A. |
author_sort | Ravindranathan, Sruthi |
collection | PubMed |
description | Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects of various biochemical properties, namely degree of deacetylation (DDA), viscosity/polymer length and endotoxin levels, on immune responses by antigen presenting cells (APCs). Chitosan solutions from various sources were treated with mouse and human APCs (macrophages and/or dendritic cells) and the amount of tumor necrosis factor-α (TNF-α) released by the cells was used as an indicator of immunoreactivity. Our results indicate that only endotoxin content and not DDA or viscosity influenced chitosan-induced immune responses. Our data also indicate that low endotoxin chitosan (<0.01 EU/mg) ranging from 20 to 600 cP and 80% to 97% DDA is essentially inert. This study emphasizes the need for more complete characterization and purification of chitosan in preclinical studies in order for this valuable biomaterial to achieve widespread clinical application. |
format | Online Article Text |
id | pubmed-4882565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-48825652016-05-27 Effect of Chitosan Properties on Immunoreactivity Ravindranathan, Sruthi Koppolu, Bhanu prasanth Smith, Sean G. Zaharoff, David A. Mar Drugs Article Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects of various biochemical properties, namely degree of deacetylation (DDA), viscosity/polymer length and endotoxin levels, on immune responses by antigen presenting cells (APCs). Chitosan solutions from various sources were treated with mouse and human APCs (macrophages and/or dendritic cells) and the amount of tumor necrosis factor-α (TNF-α) released by the cells was used as an indicator of immunoreactivity. Our results indicate that only endotoxin content and not DDA or viscosity influenced chitosan-induced immune responses. Our data also indicate that low endotoxin chitosan (<0.01 EU/mg) ranging from 20 to 600 cP and 80% to 97% DDA is essentially inert. This study emphasizes the need for more complete characterization and purification of chitosan in preclinical studies in order for this valuable biomaterial to achieve widespread clinical application. MDPI 2016-05-11 /pmc/articles/PMC4882565/ /pubmed/27187416 http://dx.doi.org/10.3390/md14050091 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ravindranathan, Sruthi Koppolu, Bhanu prasanth Smith, Sean G. Zaharoff, David A. Effect of Chitosan Properties on Immunoreactivity |
title | Effect of Chitosan Properties on Immunoreactivity |
title_full | Effect of Chitosan Properties on Immunoreactivity |
title_fullStr | Effect of Chitosan Properties on Immunoreactivity |
title_full_unstemmed | Effect of Chitosan Properties on Immunoreactivity |
title_short | Effect of Chitosan Properties on Immunoreactivity |
title_sort | effect of chitosan properties on immunoreactivity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882565/ https://www.ncbi.nlm.nih.gov/pubmed/27187416 http://dx.doi.org/10.3390/md14050091 |
work_keys_str_mv | AT ravindranathansruthi effectofchitosanpropertiesonimmunoreactivity AT koppolubhanuprasanth effectofchitosanpropertiesonimmunoreactivity AT smithseang effectofchitosanpropertiesonimmunoreactivity AT zaharoffdavida effectofchitosanpropertiesonimmunoreactivity |